Search Results
Mar 31, 2026, 07:00 ET Una donación sin precedentes permite a la Universidad de Cambridge crear la Rokos School of Government
ciencias sociales y las humanidades.La facultad iniciará su actividad en otoño de 2026 y acogerá a un número creciente de estudiantes de doctorado (PhD) y máster, tanto dentro de la propia facultad como mediante nombramientos conjuntos con distintos departamentos de la Universidad.Para dar apoyo
More news about: University of Cambridge
Mar 31, 2026, 07:00 ET Una donación sin precedentes permite a la Universidad de Cambridge crear la Rokos School of Government
ciencias sociales y las humanidades.La facultad iniciará su actividad en otoño de 2026 y acogerá a un número creciente de estudiantes de doctorado (PhD) y máster, tanto dentro de la propia facultad como mediante nombramientos conjuntos con distintos departamentos de la Universidad.Para dar apoyo
More news about: University of Cambridge
Mar 31, 2026, 07:00 ET Rekordspende ermöglicht der Universität Cambridge, die Rokos School of Government zu gründen
an Girton, um die ehrgeizige Vision des Colleges zu unterstützen.Am Queens' College Cambridge unterstützt Chris Rokos das Alexander Crummell PhD Scholarship und das Rokos-Menon Senior Research Fellowship. Außerdem unterstützt er das Centre for Climate Repair der Universität Cambridge.Mit
More news about: University of Cambridge
Mar 31, 2026, 07:00 ET Un don record permet à l'université de Cambridge de créer la Rokos School of Government
afin de soutenir la vision ambitieuse de l'établissement.Au Queens' College de Cambridge, Rokos est l'un des donateurs de l'Alexander Crummell PhD Scholarship, une bourse destinée aux doctorants, ainsi que du Rokos-Menon Senior Research Fellowship, une bourse destinée au financement de la recherche.
More news about: University of Cambridge
Mar 31, 2026, 07:00 ET रिकॉर्ड तोड़ दान से कैम्ब्रिज यूनिवर्सिटी को रोकोस स्कूल ऑफ गवर्नमेंट स्थापित करने में मदद मिली
महत्वाकांक्षी उद्देश्य के समर्थन में गिर्टन कॉलेज को अतिरिक्त 50 लाख पाउंड का अनुदान दिया।कैम्ब्रिज के क्वीन्स कॉलेज में रोकोस, एलेक्ज़ेंडर क्रम्मेल PhD स्कॉलरशिप और रोकोस-मेनन सीनियर रिसर्च फेलोशिप का समर्थन करते हैं। वे कैम्ब्रिज यूनिवर्सिटी सेंटर फॉर क्लाइमेट रिपेयर को भी सहयोग प्रदान करते हैं।अपनी
More news about: University of Cambridge
Mar 31, 2026, 06:45 ET Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
portfolio of OX2R agonists with a level of depth and breadth that could help redefine what's possible in neuroscience," said Mario Alberto Accardi, PhD, Chief Executive Officer of Centessa and Founder of the Orexin Program. "Driven by a bold vision, our team has advanced an innovative portfolio with
More news about: Eli Lilly and Company
Mar 31, 2026, 05:00 ET Resilience Care Expands to U.S. Market, Adds Veteran Digital Health Leaders to Support Growth with Oncology Providers
entry and growth is a powerhouse US advisory board of digital health and oncology industry veterans, including:Eddie Martucci, PhD (President, U.S.): Biotech entrepreneur and co-founder of Akili Interactive, known for securing the first FDA authorization for a prescription digital
More news about: Resilience Care
Mar 30, 2026, 17:40 ET BTQ Technologies Provides Full-Year 2025 Corporate Update Highlighting Commercial Progress Across QCIM, QPerfect, QSSN and Bitcoin Quantum
securing its call option as part of the pathway toward full integration. During the quarter, QPerfect brought its team to full strength with eight new PhD-level hires across research, development, hardware, DevOps, and applications, while also publishing three research papers focused on benchmarking quantum
More news about: BTQ Technologies Corp.
Mar 30, 2026, 16:00 ET Devonian Reports Results of its Annual General and Special Meeting of Shareholders
Wainwright and co-founder of DiamiR Biosciences. She brings deep expertise in healthcare fundraising, strategic advisory, and operations. She holds a PhD in Biomedical Sciences from Mount Sinai School of Medicine and an Honors MBA from Baruch College.Luc Buisson is a Senior Strategic and
More news about: Devonian Health Group Inc.
Mar 30, 2026, 12:34 ET Skyhawk Therapeutics Announces its Founding Scientific Advisory Board Chairman Receives the American Cancer Society's 2026 Medal of Honor
extraordinary scientist and leader across many fields and organizations. His recognition from ACS is richly deserved," said Dr. Benjamin L. Ebert, MD, PhD, co-founding member of Skyhawk's SAB and President and CEO of Dana-Farber Cancer Institute. "As founding Chairman of Skyhawk's SAB, Tyler has been a
More news about: Skyhawk Therapeutics
Mar 30, 2026, 10:14 ET CurePSP Convenes Bipartisan Congressional Briefing to Advance PSP, CBD and MSA Research
all its services. CurePSP is a registered 501(c)(3) charity within the United States (EIN: 52-1704978).Contact:Kristophe Diaz, PhDChief Executive [email protected]
More news about: CurePSP, Inc.
Mar 30, 2026, 09:25 ET FDA Approves High Dose Regimen of SPINRAZA for People Living with SMA
ensuring individuals and families living with SMA understand what this means and making sure they have a clear path to access," said Jackie Glascock, PhD, Chief Scientific Officer at Cure SMA. "We are committed to partnering with Biogen and healthcare providers to support education, access, and implementation
More news about: Cure SMA
Mar 30, 2026, 09:00 ET Jefferson is First Organization to Earn URAC's Community Health Worker Program Accreditation
"At Jefferson, we believe community health workers are essential to advancing equitable care," said Christine James, PhD, LSW, Director of the Community Health Worker Academy. "Becoming the first organization in the country to earn URAC's accreditation validates the strength
More news about: URAC
Mar 30, 2026, 08:30 ET Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO, and Phil Tennant, Chief Commercial Officer, of Precigen, will participate in a virtual fireside chat with H.C. Wainwright on March
More news about: Precigen, Inc.
Mar 29, 2026, 20:30 ET Insilico Medicine Announces Global R&D Collaboration with Lilly
world models of human and animal life, we can identify multi-purpose targets driving multiple diseases at the same time," said Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine. "Working with Lilly, we aim to deliver transformative therapies that treat diseases with high unmet need.
More news about: Insilico Medicine
Mar 29, 2026, 18:09 ET Better by MTA amplía su red mundial de élite con nuevos miembros Platinum distinguidos
anillos intracorneales y procedimientos refractivos. Los servicios están disponibles en inglés, español y hebreo.Dr. Patrick Tonnard, MD, PhDDirector ejecutivo y fundador, Centro de Cirugía Plástica y Medicina Estética Coupure 2 (EMC²) – Gante, BélgicaEl Dr. Patrick Tonnard
More news about: Medical Tourism Association
Mar 29, 2026, 18:06 ET Better by MTA amplia sua rede global de elite com novos e renomados membros Platinum
de anel intracorneano e procedimentos refrativos. Os serviços estão disponíveis em inglês, espanhol e hebraico.Dr. Patrick Tonnard, MD, PhDCEO e fundador do Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, BélgicaDr. Patrick Tonnard
More news about: Medical Tourism Association
Mar 29, 2026, 08:57 ET n6 Launches icon16™, Expanding AutoNorm™ Adaptive Amplification to Lower-Throughput NGS Workflows
"Sequencing technology has advanced rapidly, but the thermocycler at the center of library preparation has barely changed in decades," said Pranav Patel, PhD, MBA, co-founder and CEO of n6. "With icon96 we introduced AutoNorm to replace the one-size-fits-all approach to amplification. icon16
More news about: n6
Mar 28, 2026, 14:00 ET Dual Imaging Identifies Cause of Heart Attack in Patients Without Blocked Arteries
Chang Yu, PhD; and
More news about: NYU Langone Health
Mar 28, 2026, 12:36 ET Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting
standard of care biologic treatment, which can have lower response rates in more severe patients as compared to moderate patients," said Raj Chovatiya, MD, PhD, MSCI, FAAD. "We believe its novel agonist mechanism to expand regulatory T cells, which act as master regulators upstream of the cytokine-specific blockade
More news about: Nektar Therapeutics
Mar 28, 2026, 10:38 ET HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
of the impact of intervention via ultrasound-facilitated catheter-directed thrombolysis with the EKOS system," said Dr. Stavros Konstantinides, MD, PhD, FESC, principal investigator of the HI-PEITHO trial and medical director, Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany.*
More news about: Boston Scientific Corporation
Mar 27, 2026, 17:31 ET Shrub Oak International School Announces Janine D'Anna, M.S. Ed., as Assistant Director of Education
forward to building on the incredible work already taking place across our programs."As a lifelong learner, she is also currently pursuing her PhD at Thomas Jefferson University.About Shrub Oak International School and The Pines at Shrub OakThe mission of Shrub Oak International
More news about: Shrub Oak International School
Mar 27, 2026, 16:45 ET Allergy & Asthma Network and Blue Marble Health Advance Digital Health Innovation with Evidence-Based Platform for Asthma Self-Management
Health's approach: technology built with patients and clinicians, not just for them, produces platforms people actually want to use," Sheryl Flynn, PT, PhD, CEO of Blue Marble Health. "The strong usability and feasibility outcomes we achieved with our Health in Motion – BREATHE Platform give us tremendous
More news about: Allergy & Asthma Network
Mar 27, 2026, 10:34 ET Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members
intracorneal ring implantation, and refractive procedures. Services are available in English, Spanish, and Hebrew.Dr. Patrick Tonnard, MD, PhDCEO & Founder, Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, BelgiumDr. Patrick Tonnard
More news about: Medical Tourism Association
Mar 27, 2026, 10:06 ET Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members
intracorneal ring implantation, and refractive procedures. Services are available in English, Spanish, and Hebrew.Dr. Patrick Tonnard, MD, PhDCEO & Founder, Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, BelgiumDr. Patrick Tonnard
More news about: Medical Tourism Association